Logo

PHARMALOGIC HOLDINGS CORP 401(K) PLAN 401k Plan overview

Plan NamePHARMALOGIC HOLDINGS CORP 401(K) PLAN
Plan identification number 001

PHARMALOGIC HOLDINGS CORP 401(K) PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

PHARMALOGIC HOLDINGS CORP has sponsored the creation of one or more 401k plans.

Company Name:PHARMALOGIC HOLDINGS CORP
Employer identification number (EIN):203958410
NAIC Classification:325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMALOGIC HOLDINGS CORP 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012024-01-01MELISSA NICHOLSON
0012023-01-01
0012023-01-01BEVERLY TERRILL
0012022-01-01
0012022-01-01AARON FETTES
0012021-01-01
0012021-01-01KEITH KENNEDY
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01FRANK EDWARDS
0012016-01-01FRANK EDWARDS FRANK EDWARDS2017-07-31
0012015-01-01FRANK EDWARDS
0012014-01-01FRANK EDWARDS2015-10-07 FRANK EDWARDS2015-10-07
0012013-01-01FRANK EDWARDS
0012012-01-01FRANK EDWARDS2015-09-08
0012011-01-01THEODORE ANDERER2012-07-27 THEODORE ANDERER2012-07-27
0012010-01-01THEODORE ANDERER2011-07-21 THEODORE ANDERER2011-07-21

Financial Data on PHARMALOGIC HOLDINGS CORP 401(K) PLAN

Measure Date Value
2023 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2023 401k financial data
Total unrealized appreciation/depreciation of assets2023-12-31$0
Total transfer of assets to this plan2023-12-31$0
Total transfer of assets from this plan2023-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-12-31$0
Total income from all sources (including contributions)2023-12-31$10,656,824
Total loss/gain on sale of assets2023-12-31$0
Total of all expenses incurred2023-12-31$1,875,486
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-12-31$1,813,955
Expenses. Certain deemed distributions of participant loans2023-12-31$6,548
Value of total corrective distributions2023-12-31$1,170
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-12-31$5,795,571
Value of total assets at end of year2023-12-31$34,405,802
Value of total assets at beginning of year2023-12-31$25,624,464
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-12-31$53,813
Total interest from all sources2023-12-31$17,767
Total dividends received (eg from common stock, registered investment company shares)2023-12-31$843,318
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2023-12-31$843,318
Was this plan covered by a fidelity bond2023-12-31Yes
Value of fidelity bond cover2023-12-31$500,000
If this is an individual account plan, was there a blackout period2023-12-31No
Were there any nonexempt tranactions with any party-in-interest2023-12-31No
Contributions received from participants2023-12-31$3,266,292
Participant contributions at end of year2023-12-31$382,947
Participant contributions at beginning of year2023-12-31$318,340
Participant contributions at end of year2023-12-31$117,051
Participant contributions at beginning of year2023-12-31$600
Income. Received or receivable in cash from other sources (including rollovers)2023-12-31$904,306
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Value of net income/loss2023-12-31$8,781,338
Value of net assets at end of year (total assets less liabilities)2023-12-31$34,405,802
Value of net assets at beginning of year (total assets less liabilities)2023-12-31$25,624,464
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2023-12-31No
Were any leases to which the plan was party in default or uncollectible2023-12-31No
Investment advisory and management fees2023-12-31$40,800
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-12-31$31,744,273
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-12-31$23,444,067
Interest on participant loans2023-12-31$17,767
Value of interest in common/collective trusts at end of year2023-12-31$1,997,894
Value of interest in common/collective trusts at beginning of year2023-12-31$1,861,279
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-12-31$3,948,245
Net investment gain or loss from common/collective trusts2023-12-31$51,923
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-12-31No
Was there a failure to transmit to the plan any participant contributions2023-12-31No
Has the plan failed to provide any benefit when due under the plan2023-12-31No
Contributions received in cash from employer2023-12-31$1,624,973
Employer contributions (assets) at end of year2023-12-31$163,637
Employer contributions (assets) at beginning of year2023-12-31$178
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-12-31$1,813,955
Did the plan have assets held for investment2023-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-12-31No
Opinion of an independent qualified public accountant for this plan2023-12-31Unqualified
Accountancy firm name2023-12-31CARON & BLETZER
Accountancy firm EIN2023-12-31043499945
Total unrealized appreciation/depreciation of assets2023-01-01$0
Total transfer of assets to this plan2023-01-01$0
Total transfer of assets from this plan2023-01-01$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-01-01$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-01-01$0
Total income from all sources (including contributions)2023-01-01$10,656,824
Total loss/gain on sale of assets2023-01-01$0
Total of all expenses incurred2023-01-01$1,875,486
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-01-01$1,813,955
Expenses. Certain deemed distributions of participant loans2023-01-01$6,548
Value of total corrective distributions2023-01-01$1,170
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-01-01$5,795,571
Value of total assets at end of year2023-01-01$34,405,802
Value of total assets at beginning of year2023-01-01$25,624,464
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-01-01$53,813
Total interest from all sources2023-01-01$17,767
Total dividends received (eg from common stock, registered investment company shares)2023-01-01$843,318
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-01-01No
Total dividends received from registered investment company shares (eg mutual funds)2023-01-01$843,318
Was this plan covered by a fidelity bond2023-01-01Yes
Value of fidelity bond cover2023-01-01$500,000
If this is an individual account plan, was there a blackout period2023-01-01No
Were there any nonexempt tranactions with any party-in-interest2023-01-01No
Contributions received from participants2023-01-01$3,266,292
Participant contributions at end of year2023-01-01$382,947
Participant contributions at beginning of year2023-01-01$318,340
Participant contributions at end of year2023-01-01$117,051
Participant contributions at beginning of year2023-01-01$600
Income. Received or receivable in cash from other sources (including rollovers)2023-01-01$904,306
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-01-01No
Value of net income/loss2023-01-01$8,781,338
Value of net assets at end of year (total assets less liabilities)2023-01-01$34,405,802
Value of net assets at beginning of year (total assets less liabilities)2023-01-01$25,624,464
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-01-01No
Were any loans by the plan or fixed income obligations due to the plan in default2023-01-01No
Were any leases to which the plan was party in default or uncollectible2023-01-01No
Investment advisory and management fees2023-01-01$40,800
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-01-01$31,744,273
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-01-01$23,444,067
Interest on participant loans2023-01-01$17,767
Value of interest in common/collective trusts at end of year2023-01-01$1,997,894
Value of interest in common/collective trusts at beginning of year2023-01-01$1,861,279
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-01-01$3,948,245
Net investment gain or loss from common/collective trusts2023-01-01$51,923
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-01-01No
Was there a failure to transmit to the plan any participant contributions2023-01-01No
Has the plan failed to provide any benefit when due under the plan2023-01-01No
Contributions received in cash from employer2023-01-01$1,624,973
Employer contributions (assets) at end of year2023-01-01$163,637
Employer contributions (assets) at beginning of year2023-01-01$178
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-01-01$1,813,955
Did the plan have assets held for investment2023-01-01Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-01-01No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-01-01No
Opinion of an independent qualified public accountant for this plan2023-01-011
Accountancy firm name2023-01-01CARON & BLETZER
Accountancy firm EIN2023-01-01043499945
2022 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total transfer of assets to this plan2022-12-31$3,758,124
Total transfer of assets from this plan2022-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$-367,493
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$1,900,059
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$1,800,240
Expenses. Certain deemed distributions of participant loans2022-12-31$307
Value of total corrective distributions2022-12-31$6,730
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$3,947,677
Value of total assets at end of year2022-12-31$25,624,464
Value of total assets at beginning of year2022-12-31$24,133,892
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$92,782
Total interest from all sources2022-12-31$14,458
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$944,454
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$944,454
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$500,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$2,465,408
Participant contributions at end of year2022-12-31$318,340
Participant contributions at beginning of year2022-12-31$273,311
Participant contributions at end of year2022-12-31$600
Participant contributions at beginning of year2022-12-31$753
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$330,947
Other income not declared elsewhere2022-12-31$41,520
Administrative expenses (other) incurred2022-12-31$92,782
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-2,267,552
Value of net assets at end of year (total assets less liabilities)2022-12-31$25,624,464
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$24,133,892
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$23,444,067
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$22,194,496
Interest on participant loans2022-12-31$14,458
Value of interest in common/collective trusts at end of year2022-12-31$1,861,279
Value of interest in common/collective trusts at beginning of year2022-12-31$1,664,017
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-5,342,437
Net investment gain or loss from common/collective trusts2022-12-31$26,835
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$1,151,322
Employer contributions (assets) at end of year2022-12-31$178
Employer contributions (assets) at beginning of year2022-12-31$1,315
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$1,800,240
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31CARON & BLETZER
Accountancy firm EIN2022-12-31043499945
Total unrealized appreciation/depreciation of assets2022-01-01$0
Total transfer of assets to this plan2022-01-01$3,758,124
Total transfer of assets from this plan2022-01-01$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-01-01$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-01-01$0
Total income from all sources (including contributions)2022-01-01$-367,493
Total loss/gain on sale of assets2022-01-01$0
Total of all expenses incurred2022-01-01$1,900,059
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-01-01$1,800,240
Expenses. Certain deemed distributions of participant loans2022-01-01$307
Value of total corrective distributions2022-01-01$6,730
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-01-01$3,947,677
Value of total assets at end of year2022-01-01$25,624,464
Value of total assets at beginning of year2022-01-01$24,133,892
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-01-01$92,782
Total interest from all sources2022-01-01$14,458
Total dividends received (eg from common stock, registered investment company shares)2022-01-01$944,454
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-01-01No
Total dividends received from registered investment company shares (eg mutual funds)2022-01-01$944,454
Was this plan covered by a fidelity bond2022-01-01Yes
Value of fidelity bond cover2022-01-01$500,000
If this is an individual account plan, was there a blackout period2022-01-01No
Were there any nonexempt tranactions with any party-in-interest2022-01-01No
Contributions received from participants2022-01-01$2,465,408
Participant contributions at end of year2022-01-01$318,340
Participant contributions at beginning of year2022-01-01$273,311
Participant contributions at end of year2022-01-01$600
Participant contributions at beginning of year2022-01-01$753
Income. Received or receivable in cash from other sources (including rollovers)2022-01-01$330,947
Other income not declared elsewhere2022-01-01$41,520
Administrative expenses (other) incurred2022-01-01$92,782
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-01-01No
Value of net income/loss2022-01-01$-2,267,552
Value of net assets at end of year (total assets less liabilities)2022-01-01$25,624,464
Value of net assets at beginning of year (total assets less liabilities)2022-01-01$24,133,892
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-01-01No
Were any loans by the plan or fixed income obligations due to the plan in default2022-01-01No
Were any leases to which the plan was party in default or uncollectible2022-01-01No
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-01-01$23,444,067
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-01-01$22,194,496
Interest on participant loans2022-01-01$14,458
Value of interest in common/collective trusts at end of year2022-01-01$1,861,279
Value of interest in common/collective trusts at beginning of year2022-01-01$1,664,017
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-01-01$-5,342,437
Net investment gain or loss from common/collective trusts2022-01-01$26,835
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-01-01No
Was there a failure to transmit to the plan any participant contributions2022-01-01No
Has the plan failed to provide any benefit when due under the plan2022-01-01No
Contributions received in cash from employer2022-01-01$1,151,322
Employer contributions (assets) at end of year2022-01-01$178
Employer contributions (assets) at beginning of year2022-01-01$1,315
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-01-01$1,800,240
Did the plan have assets held for investment2022-01-01Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-01-01No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-01-01No
Opinion of an independent qualified public accountant for this plan2022-01-011
Accountancy firm name2022-01-01CARON & BLETZER
Accountancy firm EIN2022-01-01043499945
2021 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total transfer of assets to this plan2021-12-31$0
Total transfer of assets from this plan2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$5,745,190
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$2,054,756
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$1,967,218
Expenses. Certain deemed distributions of participant loans2021-12-31$4,816
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$2,673,312
Value of total assets at end of year2021-12-31$24,133,892
Value of total assets at beginning of year2021-12-31$20,443,458
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$82,722
Total interest from all sources2021-12-31$10,451
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$1,168,738
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$1,168,738
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$500,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$1,680,934
Participant contributions at end of year2021-12-31$273,311
Participant contributions at beginning of year2021-12-31$160,158
Participant contributions at end of year2021-12-31$753
Participant contributions at beginning of year2021-12-31$38,538
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$230,719
Other income not declared elsewhere2021-12-31$27,144
Administrative expenses (other) incurred2021-12-31$82,722
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$3,690,434
Value of net assets at end of year (total assets less liabilities)2021-12-31$24,133,892
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$20,443,458
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$22,194,496
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$18,357,917
Interest on participant loans2021-12-31$10,451
Value of interest in common/collective trusts at end of year2021-12-31$1,664,017
Value of interest in common/collective trusts at beginning of year2021-12-31$1,864,797
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$1,840,486
Net investment gain or loss from common/collective trusts2021-12-31$25,059
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$761,659
Employer contributions (assets) at end of year2021-12-31$1,315
Employer contributions (assets) at beginning of year2021-12-31$22,048
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$1,967,218
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31CARON & BLETZER
Accountancy firm EIN2021-12-31043499945
2020 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total transfer of assets to this plan2020-12-31$6,732,248
Total transfer of assets from this plan2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$4,976,635
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$1,637,133
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$1,582,228
Expenses. Certain deemed distributions of participant loans2020-12-31$4,867
Value of total corrective distributions2020-12-31$382
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$2,193,425
Value of total assets at end of year2020-12-31$20,443,458
Value of total assets at beginning of year2020-12-31$10,371,708
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$49,656
Total interest from all sources2020-12-31$8,651
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$680,550
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$680,550
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$500,000
If this is an individual account plan, was there a blackout period2020-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$1,470,139
Participant contributions at end of year2020-12-31$160,158
Participant contributions at beginning of year2020-12-31$150,400
Participant contributions at end of year2020-12-31$38,538
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$35,723
Other income not declared elsewhere2020-12-31$10,229
Administrative expenses (other) incurred2020-12-31$49,656
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$3,339,502
Value of net assets at end of year (total assets less liabilities)2020-12-31$20,443,458
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$10,371,708
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$18,357,917
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$9,589,003
Interest on participant loans2020-12-31$8,651
Value of interest in common/collective trusts at end of year2020-12-31$1,864,797
Value of interest in common/collective trusts at beginning of year2020-12-31$632,305
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$2,055,980
Net investment gain or loss from common/collective trusts2020-12-31$27,800
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$687,563
Employer contributions (assets) at end of year2020-12-31$22,048
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$1,582,228
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Unqualified
Accountancy firm name2020-12-31CARON & BLETZER
Accountancy firm EIN2020-12-31043499945
2019 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total transfer of assets to this plan2019-12-31$0
Total transfer of assets from this plan2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$3,486,005
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$1,031,986
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$1,001,524
Value of total corrective distributions2019-12-31$737
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$1,690,293
Value of total assets at end of year2019-12-31$10,371,708
Value of total assets at beginning of year2019-12-31$7,917,689
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$29,725
Total interest from all sources2019-12-31$8,905
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$296,096
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$296,096
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$1,029,968
Participant contributions at end of year2019-12-31$150,400
Participant contributions at beginning of year2019-12-31$197,603
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$196,098
Other income not declared elsewhere2019-12-31$34,522
Administrative expenses (other) incurred2019-12-31$29,725
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$2,454,019
Value of net assets at end of year (total assets less liabilities)2019-12-31$10,371,708
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$7,917,689
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$9,589,003
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$5,182,576
Interest on participant loans2019-12-31$8,905
Value of interest in common/collective trusts at end of year2019-12-31$632,305
Value of interest in common/collective trusts at beginning of year2019-12-31$2,537,510
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$891,188
Net investment gain or loss from common/collective trusts2019-12-31$565,001
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$464,227
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$1,001,524
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31CARON & BLETZER
Accountancy firm EIN2019-12-31043499945
2018 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total transfer of assets to this plan2018-12-31$0
Total transfer of assets from this plan2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$859,867
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$535,300
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$495,978
Expenses. Certain deemed distributions of participant loans2018-12-31$6,025
Value of total corrective distributions2018-12-31$3,958
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$1,382,713
Value of total assets at end of year2018-12-31$7,917,689
Value of total assets at beginning of year2018-12-31$7,593,122
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$29,339
Total interest from all sources2018-12-31$6,522
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$270,250
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$270,250
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$500,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$908,326
Participant contributions at end of year2018-12-31$197,603
Participant contributions at beginning of year2018-12-31$118,828
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$38,444
Other income not declared elsewhere2018-12-31$31,212
Administrative expenses (other) incurred2018-12-31$29,339
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$324,567
Value of net assets at end of year (total assets less liabilities)2018-12-31$7,917,689
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$7,593,122
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$5,182,576
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$4,785,053
Interest on participant loans2018-12-31$6,522
Value of interest in common/collective trusts at end of year2018-12-31$2,537,510
Value of interest in common/collective trusts at beginning of year2018-12-31$2,689,241
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-617,626
Net investment gain or loss from common/collective trusts2018-12-31$-213,204
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$435,943
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$495,978
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31CARON & BLETZER
Accountancy firm EIN2018-12-31043499945
2017 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total transfer of assets to this plan2017-12-31$0
Total transfer of assets from this plan2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$2,697,036
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$403,177
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$371,496
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$1,732,498
Value of total assets at end of year2017-12-31$7,593,122
Value of total assets at beginning of year2017-12-31$5,299,263
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$31,681
Total interest from all sources2017-12-31$5,112
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$140,350
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$140,350
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$500,000
If this is an individual account plan, was there a blackout period2017-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$865,034
Participant contributions at end of year2017-12-31$118,828
Participant contributions at beginning of year2017-12-31$138,241
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$445,450
Other income not declared elsewhere2017-12-31$22,831
Administrative expenses (other) incurred2017-12-31$31,681
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$2,293,859
Value of net assets at end of year (total assets less liabilities)2017-12-31$7,593,122
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$5,299,263
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$4,785,053
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$2,832,040
Interest on participant loans2017-12-31$5,112
Value of interest in common/collective trusts at end of year2017-12-31$2,689,241
Value of interest in common/collective trusts at beginning of year2017-12-31$2,328,982
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$468,639
Net investment gain or loss from common/collective trusts2017-12-31$327,606
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$422,014
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$371,496
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31CARON & BLETZER
Accountancy firm EIN2017-12-31043499945
2016 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total transfer of assets to this plan2016-12-31$0
Total transfer of assets from this plan2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$1,624,141
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$261,509
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$236,743
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$1,127,525
Value of total assets at end of year2016-12-31$5,299,263
Value of total assets at beginning of year2016-12-31$3,936,631
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$24,766
Total interest from all sources2016-12-31$5,404
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$80,185
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$80,185
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$394,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$673,458
Participant contributions at end of year2016-12-31$138,241
Participant contributions at beginning of year2016-12-31$114,550
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$130,458
Other income not declared elsewhere2016-12-31$16,962
Administrative expenses (other) incurred2016-12-31$24,766
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$1,362,632
Value of net assets at end of year (total assets less liabilities)2016-12-31$5,299,263
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$3,936,631
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$2,832,040
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$2,129,676
Interest on participant loans2016-12-31$5,404
Value of interest in common/collective trusts at end of year2016-12-31$2,328,982
Value of interest in common/collective trusts at beginning of year2016-12-31$1,692,405
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$151,659
Net investment gain or loss from common/collective trusts2016-12-31$242,406
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$323,609
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$236,743
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31CARON & BLETZER
Accountancy firm EIN2016-12-31043499945
2015 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total transfer of assets to this plan2015-12-31$0
Total transfer of assets from this plan2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$933,549
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$677,862
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$653,880
Expenses. Certain deemed distributions of participant loans2015-12-31$15
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$978,419
Value of total assets at end of year2015-12-31$3,936,631
Value of total assets at beginning of year2015-12-31$3,680,944
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$23,967
Total interest from all sources2015-12-31$3,697
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$131,598
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$131,598
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$369,000
If this is an individual account plan, was there a blackout period2015-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$460,812
Participant contributions at end of year2015-12-31$114,550
Participant contributions at beginning of year2015-12-31$93,955
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$291,001
Other income not declared elsewhere2015-12-31$15,182
Administrative expenses (other) incurred2015-12-31$23,967
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$255,687
Value of net assets at end of year (total assets less liabilities)2015-12-31$3,936,631
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$3,680,944
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$2,129,676
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$2,133,667
Interest on participant loans2015-12-31$3,697
Value of interest in common/collective trusts at end of year2015-12-31$1,692,405
Value of interest in common/collective trusts at beginning of year2015-12-31$1,453,322
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-158,455
Net investment gain or loss from common/collective trusts2015-12-31$-36,892
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$226,606
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$653,880
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31CARON & BLETZER
Accountancy firm EIN2015-12-31043499945
2014 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total transfer of assets to this plan2014-12-31$0
Total transfer of assets from this plan2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$786,801
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$485,209
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$463,380
Expenses. Certain deemed distributions of participant loans2014-12-31$644
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$544,028
Value of total assets at end of year2014-12-31$3,680,944
Value of total assets at beginning of year2014-12-31$3,379,352
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$21,185
Total interest from all sources2014-12-31$4,455
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$135,717
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$135,717
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$338,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$364,827
Participant contributions at end of year2014-12-31$93,955
Participant contributions at beginning of year2014-12-31$99,072
Other income not declared elsewhere2014-12-31$13,833
Administrative expenses (other) incurred2014-12-31$21,185
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$301,592
Value of net assets at end of year (total assets less liabilities)2014-12-31$3,680,944
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$3,379,352
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$2,133,667
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$2,134,381
Interest on participant loans2014-12-31$4,455
Value of interest in common/collective trusts at end of year2014-12-31$1,453,322
Value of interest in common/collective trusts at beginning of year2014-12-31$1,145,899
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$18,913
Net investment gain or loss from common/collective trusts2014-12-31$69,855
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$179,201
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$463,380
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31CARON & BLETZER
Accountancy firm EIN2014-12-31043499945
2013 : PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$1,152,478
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$611,251
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$598,634
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$559,092
Value of total assets at end of year2013-12-31$3,379,352
Value of total assets at beginning of year2013-12-31$2,838,125
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$12,617
Total interest from all sources2013-12-31$3,726
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$79,397
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$79,397
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$284,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$379,146
Participant contributions at end of year2013-12-31$99,072
Participant contributions at beginning of year2013-12-31$74,336
Other income not declared elsewhere2013-12-31$10,932
Administrative expenses (other) incurred2013-12-31$12,617
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$541,227
Value of net assets at end of year (total assets less liabilities)2013-12-31$3,379,352
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$2,838,125
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$2,134,381
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$1,817,358
Interest on participant loans2013-12-31$3,726
Value of interest in common/collective trusts at end of year2013-12-31$1,145,899
Value of interest in common/collective trusts at beginning of year2013-12-31$946,431
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$302,755
Net investment gain or loss from common/collective trusts2013-12-31$196,576
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$179,946
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$598,634
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31CARON & BLETZER
Accountancy firm EIN2013-12-31043499945

Form 5500 Responses for PHARMALOGIC HOLDINGS CORP 401(K) PLAN

2023: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2023 form 5500 responses
2023-01-01Type of plan entitySingle employer plan
2023-01-01Submission has been amendedNo
2023-01-01This submission is the final filingNo
2023-01-01This return/report is a short plan year return/report (less than 12 months)No
2023-01-01Plan is a collectively bargained planNo
2023-01-01Plan funding arrangement – TrustYes
2023-01-01Plan benefit arrangement - TrustYes
2022: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes
2020: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement - TrustYes
2019: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2018: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement - TrustYes
2017: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: PHARMALOGIC HOLDINGS CORP 401(K) PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S1